Integra LifeSciences Holdings (IART) 2011年年度报告「NASDAQ」.pdf

1、LIMITING UNCERTAINTY IS HOW WE MAKE A DIFFERENCE.Integra 2011 Annual ReportTotal RevenuesOperating Cash FlowDiluted Earnings Per ShareSelected Financial Data:Company at a Glance Founded in 1989 and headquartered in Plainsboro,NJ Growing share in spine and extremity reconstruction within the orthoped

2、ic market Market leadership in neurosurgery and medical instruments Employs approximately 3,400 worldwide Sells through direct reps in the U.S.,Canada,major European markets and Australia,and through distributors in these and over 100 countries2011 Revenues by Geographic AreaRegion 2011 Revenues ($i

3、n Millions)United States$593Europe$95Asia Pacifi c$44Other Foreign$482011 Revenues by Product CategoryProduct Category%of Total Revenues Key Product Areas 2011 RevenuesOrthopedics 42%MIS spine system,traditional spine fusion,$329 Million extremity reconstruction,orthobiologics,skin&woundNeurosurgery

4、 37%Dural gra?,cranial stabilization,$285 Million CSF management,ultrasonic aspiration,neuromonitoringInstruments 21%General and specialty hand-held surgical$166 Million instruments in the hospital and offi ce-based se?ings,surgical headlights Dear Shareholders:I am excited and honored to have been

5、named President and CEO of Integra.I came here knowing I wasjoining a strong company with great growth opportunities,and I saw a once-in-a-lifetime opportunity to helpIntegra embark on the next phase of its journey to become a multi-billion dollar global medical device company.I have spent the last

6、year learning about the company and meeting with our key stakeholders ourcustomers,investors,and employees and I am confident that together,we will grow shareholder value whilemaking a difference in the health of millions of patients.Accomplishments and Initiatives2011 was an important year for Inte